Historical Moment For Pfizer: First Late-Stage Vaccine To Be 90% Effective Against COVID-19
PFE

Covid Rapid Antigen Testing Partnership Formed – Therma Bright Is In Play – Should You Buy   Pfizer ($PFE) is the first company to release late-stage research results showing that a vaccine candidate shows a very high positive response. Pfizer and German partner BioNTech ($BNTX) now want to discuss the results with global regulatory authorities…

Galapagos Enters November With Flair: New Revelation About Toledo Target Family
GLPG

Galapagos NV (NASDAQ: $GLPG) unveils the Toledo target family as a series of salt-inducible kinase inhibitors. Toledo demonstrates a dual mechanism of action characterized by stimulation of anti-inflammatory cytokines and inhibition of pro-inflammatory cytokines. Galapagos also presented new preclinical data and results in healthy volunteers today. Furthermore, it explains its broad program to discover and…